CHRDL2's precise functional role in these cancers is not always clear but it has been shown to increase cellular proliferation, migration and invasion in osteosarcoma cell lines by regulation of the PI3k/AKT pathways through binding to BMP9 [30]. This evidence concerns the gene AKT1 and cancer.